کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1934633 | 1050645 | 2008 | 6 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase](/preview/png/1934633.png)
Tumor cell migration is considered as a major event in the metastatic cascade. Here we examined the effect of (−)-epigallocatechin-3-gallate (EGCG) on migration capacity and molecular mechanism using 4T1 murine mammary cancer cells as a model. Using an in vitro migration assay, we found that treatment of 4T1 cells with EGCG resulted in concentration-dependent inhibition of migration of these cells. The migration capacity of cells was reduced in presence of NG-nitro-l-arginine methyl ester (l-NAME), an inhibitor of nitric oxide synthase. EGCG suppressed the elevated levels of endogenous NO/NOS in 4T1 cells and blocked the migration promoting capacity of l-arginine. Treatment with guanylate cyclase inhibitor 1-H-[1,2,4]oxadiaxolo[4,3-a]quinolalin-1-one (ODQ) reduced the migration of 4T1 cells. EGCG reduced the elevated levels of cGMP in cancer cells and blocked the migration restoring activity of 8-Br cGMP (cGMP analogue). These results indicate for the first time that EGCG inhibits mammary cancer cell migration through the inhibition of NO/NOS and guanylate cyclase.
Journal: Biochemical and Biophysical Research Communications - Volume 375, Issue 1, 10 October 2008, Pages 162–167